Limosilactobacillus reuteri DSM 17938 as a probiotic in preterm infants: An updated systematic review with meta-analysis and trial sequential analysis.
- 2023-10-13
- Meta-Analysis · n = 2,284
- JPEN. Journal of parenteral and enteral nutrition 47(8)
- Ju Li Ang
- Gayatri Athalye-Jape
- Shripada Rao
- Max Bulsara
- Sanjay Patole
- PubMed: 37742098
- DOI: 10.1002/jpen.2564
- High evidence
- Infants
Meta-analysis of RCTs showed LR significantly reduced NEC stage ≥II (risk ratio [RR], 0.57 [95% CI, 0.37-0.87]; P = 0.009)
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes